文献速递血栓与止血

静脉血栓栓塞诊断策略的成本效益:系统综述

Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review.
PubMed 文献 · Blood Adv · 2022-01-01

为支持美国血液学会静脉血栓栓塞诊断指南,本系统综述检索Medline、Embase、NHS EED和CEA Registry,纳入49项研究(26项肺栓塞、24项深静脉血栓),评估诊断策略的成本效益。肺栓塞诊断中,含d-二聚体策略较不含d-二聚体策略更具成本效益;CTPA与V/Q扫描的成本效益关系不确定。深静脉血栓诊断中,含d-二聚体和/或超声的策略具成本效益。

要点

  • 肺栓塞诊断中,含d-二聚体策略较不含d-二聚体策略更具成本效益。
  • CTPA与V/Q扫描的成本效益关系不确定。
  • 深静脉血栓诊断中,含d-二聚体和/或超声策略具成本效益。

核心结论

  • 肺栓塞诊断中,含d-二聚体策略较不含d-二聚体策略具成本效益。
  • CTPA与V/Q扫描的成本效益关系不确定。
  • 深静脉血栓诊断中,含d-二聚体和/或超声策略具成本效益。

研究设计与样本

  • 系统综述检索Medline、Embase、NHS EED和CEA Registry。
  • 纳入49项研究,其中26项关于肺栓塞,24项关于深静脉血栓。

主要发现

  • 肺栓塞诊断中,含d-二聚体策略较不含d-二聚体策略具成本效益。
  • CTPA与V/Q扫描的成本效益关系不确定。
  • 超声或d-二聚体结果后行CTPA或V/Q扫描可能具成本效益甚至节约成本。
  • 深静脉血栓诊断中,含d-二聚体和/或超声策略具成本效益。

临床怎么用

  • 低(不太可能)VTE风险患者,使用d-二聚体作为初始检测可减少诊断性影像需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Guideline developers consider cost-effectiveness evidence in decision making to determine value for money. This consideration in the guideline development process can be informed either by formal and dedicated economic evaluations or by systematic reviews of existing studies. To inform the American Society of Hematology guideline on the diagnosis of venous thromboembolism (VTE), we conducted a systematic review focused on the cost-effectiveness of diagnostic strategies for VTE within the guideline scope. We systematically searched Medline (Ovid), Embase (Ovid), National Health Service Economic Evaluation Database, and the Cost-effectiveness Analysis Registry; summarized; and critically appraised the economic evidence on diagnostic strategies for VTE. We identified 49 studies that met our inclusion criteria, with 26 on pulmonary embolism (PE) and 24 on deep vein thrombosis (DVT). For the diagnosis of PE, strategies including d-dimer to exclude PE were cost-effective compared with strategies without d-dimer testing. The cost-effectiveness of computed tomography pulmonary angiogram (CTPA) in relation to ventilation-perfusion (V/Q) scan was inconclusive. CTPA or V/Q scan following ultrasound or d-dimer results could be cost-effective or even cost saving. For DVT, studies supporting strategies with d-dimer and/or ultrasound were cost-effective, supporting the recommendation that for patients at low (unlikely) VTE risk, using d-dimer as the initial test reduces the need for diagnostic imaging. Our systematic review informed the American Society of Hematology guideline recommendations about d-dimer, V/Q scan and CTPA for PE diagnosis, and d-dimer and ultrasound for DVT diagnosis.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Begum HA, Grewal H, et al. Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review. Blood Adv. 2022. PMID: 34607343. doi:10.1182/bloodadvances.2020003576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。